Ovarian Carcinoma, Psychiatric Disorder
Conditions
Brief summary
This clinical trial tests an adapted version of the Helping Ovarian Cancer Patients Cope (HOPE) intervention to address burnout among gynecologic oncology clinicians. Stress and burnout among gynecologic oncology clinicians can have far-reaching impacts not only on physicians at the individual level (e.g., distress, mental illness) but also at the professional (e.g., worse patient outcomes, increased errors) and societal levels (fewer physicians in this specialty, more system strain). The original Helping Ovarian Cancer Patients Cope (HOPE) is a workshop to promote hope among patients with ovarian cancer through creating positive narratives using the hope theory and social-cognitive theory. The adapted intervention for clinicals (HOPE-C) will use the same concepts but tailored to clinician experiences by fostering peer support and retelling their challenging stories and may address burnout for gynecologic oncology clinicians.
Detailed description
OUTLINE: OBJECTIVE 1 DEVELOPMENT OF INTERVENTION: Clinicians review HOPE-C intervention materials and complete an interview and questionnaire on study. OBJECTIVE 2 PILOT TRIAL: Clinicians attend HOPE-C sessions (changing their narrative, managing life's uncertainty and finding meaning) once weekly for 4 weeks, with each session lasting approximately 30-45 minutes. Clinicians complete a questionnaire before and after completing all HOPE-C sessions. OBJECTIVE 3: Clinicians may undergo an interview after completing HOPE-C sessions.
Interventions
BEHAVIORALBehavioral Intervention
Complete HOPE-C sessions
OTHERInterview
Complete interview
OTHERSurvey Administration
Ancillary studies
Sponsors
Fred Hutchinson Cancer Center
Andy Hill CARE Fund
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Age 18 years of age or older * English speaking * Able to provide informed consent * Working with patients with ovarian cancer (gynecologic oncologists, medical oncologists, nurses, social workers, and advance practice providers \[APPs\])
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Objective 1: Clinician feedback for Helping Ovarian Cancer Patients Cope-Clinician Burnout (HOPE-C) | Day 1 | Will assess clinician's feedback around the content, delivery structure, and materials for the adapted HOPE-C intervention. Qualitative Description will be used to analyze the data. |
| Objective 2: Feasibility (Accrual rate) | At time of enrollment | Feasibility cutoff includes ≥ 50% of eligible clinicians enrolling in the study. |
| Objective 2: Feasibility (Rate of intervention completion) | At 4 weeks | Feasibility cutoff includes ≥ 50% of enrolled clinicians completing all sessions. |
| Objective 2: Feasibility (Rate of survey completion) | At baseline and 2-week post-intervention | Feasibility cutoff includes ≥ 50% of enrolled clinicians completing all surveys. |
| Objective 2: Acceptability of HOPE-C | At 2-week post-intervention | Assessed by the Theoretical Framework of Acceptability (TFA) questionnaire, which is an 8-item questionnaire assessing acceptability of healthcare interventions across seven constructions: Affective Attitude, Burden, Ethicality, Intervention Coherence, Opportunity Costs, Perceived Effectiveness and Self-efficacy. Items are rated on a 5-point Likert scale (e.g., 1 = strongly dislike, 5 = strongly like) and a mean is computed across all seven constructs (n=7 items) and a single outcome is examined for the general item. Total mean score ranges from 1 to 5, with higher scores indicating greater acceptability of the intervention. |
| Objective 2: Satisfaction of HOPE-C | At 2-week post-intervention | Will be assessed by using three items assessing overall satisfaction. A cutoff score of ≥ 7 (out of 10) will be used for each satisfaction item. |
| Objective 3: Optimization of the intervention | At 2-week post-intervention | Feedback will be gathered from clinicians who participated in the intervention to assess their feedback on how to optimize the intervention in clinical settings. |
| Objective 3: Delivery of the intervention | At 2-week post-intervention | Feedback will be gathered from clinicians who participated in the intervention to assess their feedback on the delivery of the intervention in clinical settings. |
Countries
United States
Contacts
CONTACTMegan J. Shen, PhD
PRINCIPAL_INVESTIGATORMegan J. Shen, PhD
Fred Hutch/University of Washington Cancer Consortium
Outcome results
None listed